Emergent Biosolutions Inc. Operating CF/Net income

Operating CF/Net income of EBS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating CF/Net income growth rates and interactive chart. Calculated as operating cash flow divided by net income to common shareholders. Also called income quality ratio. A ratio of greater than 1.0 usually indicates high-quality income, while a ratio of less than 1.0 indicates low-quality.

Highlights and Quick Summary

  • Operating CF/Net income for the quarter ending June 30, 2023 was 0.44 (a -56.46% decrease compared to previous quarter)
  • Year-over-year quarterly Operating CF/Net income decreased by -55.21%
  • Annual Operating CF/Net income for 2022 was 0.15 (a -89.04% decrease from previous year)
  • Annual Operating CF/Net income for 2021 was 1.39 (a -20.84% decrease from previous year)
  • Annual Operating CF/Net income for 2020 was 1.76 (a -49.07% decrease from previous year)
  • Twelve month Operating CF/Net income ending June 30, 2023 was 0.46 (a 2.54% increase compared to previous quarter)
  • Twelve month trailing Operating CF/Net income decreased by -87.83% year-over-year
Trailing Operating CF/Net income for the last four month:
30 Jun '23 31 Mar '23 31 Dec '22 30 Sep '22
0.46 0.45 0.15 3.78
Visit stockrow.com/EBS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating CF/Net income of Emergent Biosolutions Inc.

Most recent Operating CF/Net incomeof EBS including historical data for past 10 years.

Interactive Chart of Operating CF/Net income of Emergent Biosolutions Inc.

Emergent Biosolutions Inc. Operating CF/Net income for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 0.44 1.01 – – –
2022 -1.05 0.98 0.28 10.08 0.15
2021 1.74 -0.51 -6.46 0.07 1.39
2020 1.32 2.66 1.38 -4.62 1.76
2019 2.61 -0.07 3.77 -4.03 3.45
2018 48.76 8.33 0.69 0.2 0.67
2017 2.28 1.04 11.7 3.97 2.52
2016 -0.34 1.27 0.18 10.57 1.05
2015 0.03 2.84 0.18 3.06 0.68
2014 1.72 3.62 2.15 1.45 3.06
2013 0.57 4.46 3.13 0.57 3.11
2012 -2.42 7.02 – – 1.69

Business Profile of Emergent Biosolutions Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic
© stockrow.com